Fortress Biotech Engages Investors in Upcoming Conferences
Fortress Biotech’s Upcoming Investor Conferences
Fortress Biotech, Inc. (Nasdaq: FBIO) is gearing up for a series of important investor conferences this October. The company, known for its pioneering initiatives in the biopharmaceutical sector, is set to share insights and engage with investors at these notable events. Lindsay A. Rosenwald, M.D., the Chairman, President and Chief Executive Officer of Fortress, will lead the discussions and presentations.
Lytham Partners Fall 2024 Investor Conference
The Lytham Partners Fall 2024 Investor Conference is a key event for stakeholders. Scheduled for October 1, 2024, at 4:15 p.m. ET, this virtual gathering features a fireside chat designed to provide a comprehensive overview of Fortress’ strategic direction and innovations. In addition to the fireside chat, there will be opportunities for one-on-one meetings with Dr. Rosenwald, allowing investors to dive deeper into the company's vision.
Accessing Conference Details
To learn more and register for the conference, attendees can visit the Lytham Partners official site. This platform will offer further insights into Fortress Biotech and the strategic initiatives that are in the pipeline, emphasizing the company's commitment to growing shareholder value.
3rd Annual ROTH Healthcare Opportunities Conference
Following the Lytham Partners event, Fortress will also participate in the 3rd Annual ROTH Healthcare Opportunities Conference on October 9, 2024. This conference is vital for healthcare-focused investors and will take place in New York. Here, Fortress will engage in one-on-one meetings, offering stakeholders another chance to connect and explore the evolving landscape of the biopharmaceutical industry.
Replay Availability
Interested parties who miss the live discussions will be relieved to know that a replay of the fireside chat from the Lytham Partners event will be available shortly after the conference. It will be accessible on Fortress' official website, providing continuous access to the insights shared during the event.
About Fortress Biotech
Fortress Biotech, Inc. is at the forefront of the biopharmaceutical industry, actively acquiring and developing innovative assets. With an impressive portfolio that includes seven marketed prescription pharmaceutical products and over 20 developmental programs, Fortress taps into significant market areas including oncology, rare diseases, and gene therapy. This diversified pipeline not only fuels the company's growth but also enhances the potential for long-term shareholder value.
Strategic Partnerships
Fortress is known for its collaborative approach, partnering with renowned academic research institutions and leading biopharmaceutical companies. Collaborators like AstraZeneca, City of Hope, and Nationwide Children’s Hospital reinforce Fortress' commitment to excellence and innovation, allowing it to maximize opportunities in various therapeutic areas.
Company Contact
For further inquiries, individuals can reach out to Jaclyn Jaffe at Fortress Biotech, Inc. For direct communication, call (781) 652-4500 or send an email to ir@fortressbiotech.com.
Media Relations
For media-related questions, Tony Plohoros at 6 Degrees is available at (908) 591-2839, or via email at tplohoros@6degreespr.com.
Frequently Asked Questions
What is Fortress Biotech’s primary focus?
Fortress Biotech focuses on acquiring and advancing biopharmaceutical assets to enhance long-term shareholder value.
When is the Lytham Partners Fall 2024 Investor Conference?
The conference is scheduled for October 1, 2024, at 4:15 p.m. ET.
How can I access the replay of the fireside chat?
The replay will be available on Fortress' website shortly after the event.
What are some of Fortress Biotech’s partnerships?
Fortress has established partnerships with organizations such as AstraZeneca and Nationwide Children’s Hospital.
Who can I contact for more information about Fortress Biotech?
Jaclyn Jaffe is the contact for inquiries, reachable at (781) 652-4500 or via email.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Remarkable Returns: A Year in Crypto Investments Explained
- Equinix: Analyzing Price-to-Earnings Ratio Insights
- Unlocking Savings: How New Construction Homes Are Changing Prices
- Strategic Opportunities Arising From China's New Stimulus Measures
- Spectral Capital's $15 Million Fundraising for Quantum Innovations
- KKR Shares Dip Amid Climate Strategy Partnership Insights
- US PCE Inflation Steady and Signals Potential Fed Action
- Empowering Communities: The Vital Role of Local Leaders
- Envestnet, Inc. Faces Major Allegations in Trade Secret Case
- Building Cultural Bridges: A Young Egyptian's Journey
Recent Articles
- CSG Systems to Host Earnings Call for Q3 2024 Insights
- Reborn Coffee Expands Global Footprint with New Thailand Locations
- ColoBarn Partners with IvedaAI™ to Elevate Security Standards
- Yoshiharu Global Co. Expands into Korean BBQ Market
- Tempus and Takeda Collaborate for Enhanced Cancer Treatment Insights
- EXL Unveils Advanced LLM for Insurance Powered by NVIDIA
- OSI Systems Secures $27 Million for Cargo Inspection Service
- Stellantis Celebrates Exceptional Suppliers at Annual Awards
- Wearables Market Set for Growth with Varied Category Trends
- AITX Expands RIO™ Security Solutions with New Order
- Forge Global Introduces Innovative Forge Price for Investments
- Rising Apartment Supply Leads to Decrease in Asking Rents
- Alivia Analytics Welcomes Manny Fernandez as SVP of Government Solutions
- Upcoming Auction Insights for FirstEnergy's Default Service Program
- Addressing Manager Stress: A Call for Workplace Transformation
- Guggenheim Treasury Service's Groundbreaking Digital Commercial Paper
- LightPath Technologies Receives Major Defense Production Order
- cove.tool's New Book Aims at Transforming Built Environment
- AdTech Holding Achieves Great Place to Work Certification
- Amerant Bancorp Inc. Unveils Attractive Stock Offering Strategy
- Essential Permitting Tips for Homeowners After Hurricane Helene
- Princeton TMX Recognized as a Top Innovator in FreightTech
- SysAid Celebrates Recognition in Gartner Hype Cycle 2024 Reports
- Maximizing Returns: How to Generate Income from Costco Stock
- Finvi Partners with Divinity Software to Enhance Velosidy Efforts
- GITAI USA Moves to Larger HQ, Boosts Space Robotics Production
- Insights from CNBC's Final Trades: Key Stock Picks
- Unlocking the Mysteries of Precognition: Insights from Jon Taylor
- Discover These 3 Undervalued Materials Stocks to Watch
- Cascadia Windows & Doors Sets New Standards with EPDs
- Gulf Energy Information Joins Forces with Chempute Software
- Delaware LIVE News Enhances Structure for Local Coverage Growth
- Revolutionizing Financial Education with Vanguard AI 4.0
- Raising Awareness on Foster Care Housing Challenges Nationwide
- Engaging Discussions Await at 2025 CONNECTIONS™ Conferences
- Short Shorts Film Festival & Asia 2024 Autumn Screening Launch
- Empowering Women: SeeHer's Groundbreaking Campaign Launch
- Looma Secures $10 Million Funding to Enhance Store Media
- Researchers Discover New Drug Potential to Combat Aging
- AbbVie Reports Positive Phase 3 Trial Results for Tavapadon
- NaaS Technology Forms Strategic Alliance with IM Motors for EV Charging
- PTC Therapeutics Advances Huntington's Treatment with FDA's Support
- Mizuho Securities Projects Strong Performance for Accenture
- Accenture's Strategic Moves Spark Confidence Among Analysts
- BMO Capital Adjusts Ubisoft Target But Remains Positive
- Growth Momentum and Economic Stimulus Drive Market Trends
- Lactase Market Trends Predict Growth to $369.96 Million by 2032
- Investing in Cybersecurity: Top Stocks for Future Growth
- Enlivex Secures Danish Approval to Advance Allocetra Trials
- Insights on Sterilization Equipment Market Growth and Trends